Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Aligos Therapeutics (5WK0) Drug Pipeline

2 Followers
Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
Pevifoscorvir SodiumChronic Hepaititis B InfectionsPhase IRecruitingSingle-Dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Pevifoscorvir Sodium (ALG-000184) in Subjects With Moderate Hepatic Impairment and in Healthy Subjects With Normal Hepatic FunctionDec 15, 2025
Pevifoscorvir SodiumChronic Hepatitis B InfectionPhase IRecruitingSingle Dose Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Pevifoscorvir Sodium (ALG-000184) in Participants With Renal Impairment and in Healthy Participants With Normal Renal FunctionDec 15, 2025―
Alg-000184, TdfChronic Hepatitis B InfectionPhase IIRecruitingA Study Evaluating the Efficacy and Safety of ALG-000184 Compared With Tenofovir Disoproxil Fumarate in Untreated HBeAg-Positive and HBeAg- Negative Adult Subjects With Chronic Hepatitis B (B-SUPREME)Apr 22, 2025
Alg-055009Healthy Volunteer StudyPhase ICompletedA Phase 1 Study in Healthy Volunteers to Evaluate the Relative Bioavailability of ALG-055009 FormulationsMar 24, 2025―
Alg-097558Covid 19Phase ICompletedA Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ALG-097558 in Subjects With Renal Impairment and in Healthy Subjects With Normal Renal FunctionNov 12, 2024―
Carbamazepine, Itraconazole, Alg-000184Healthy VolunteerPhase IActive Not RecruitingA Multi-part Study of ALG-000184 to Evaluate Safety, Tolerability, Pharmacokinetics and Drug-drug Interaction Potential After Single and Multiple Doses in Healthy VolunteersSep 25, 2024―
Alg-097558Covid-19Phase ICompletedA Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ALG-097558 in Subjects With Hepatic Impairment and in Healthy Subjects With Normal Hepatic FunctionAug 20, 2024―
Alg-055009Nash, Nonalcoholic Steatohepatitis, Metabolic Dysfunction-associated Steatohepatitis, MashPhase IICompletedALG-055009 in Non-cirrhotic Adults With MASH (HERALD)Mar 15, 2024―
Rosuvastatin, Atorvastatin, Alg-055009Healthy VolunteersPhase ICompletedA Phase 1 Study to Evaluate the Drug-Drug Interaction Potential Between ALG-055009 and Statin Therapy(Ies)Nov 03, 2023―
Midazolam, Carbamazepine, Itraconazole, Alg-097558, Alg-097558 In Solution Formulation, Alg-097558 In Tablet FormulationCovid-19Phase ICompletedA First-in-Human Multi-Part Phase 1 Study in Healthy Volunteers to Evaluate the Safety, Tolerability, Pharmacokinetics, and Drug-Drug Interaction Potential of Single and Multiple Doses of ALG-097558Apr 10, 2023―

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Aligos Therapeutics, Inc. (DE:5WK0) have in its pipeline
Aligos Therapeutics DE:5WK0 is currently developing the following drugs: Pevifoscorvir Sodium, Alg-000184, Tdf, Alg-055009, Alg-097558, Carbamazepine, Itraconazole, Alg-000184, Rosuvastatin, Atorvastatin, Alg-055009, Midazolam, Carbamazepine, Itraconazole, Alg-097558, Alg-097558 In Solution Formulation, Alg-097558 In Tablet Formulation, Alg-000184, Entecavir. These drug candidates are in various stages of clinical development as the company works toward FDA approval.